| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/22/2010 | WO2010083220A1 Benzoxazole inhibitors of poly(adp-ribose)polymerase |
| 07/22/2010 | WO2010083215A2 Composition and method for the treatment of diseases affected by apoptosis |
| 07/22/2010 | WO2010083203A2 Non-embryonic stem cells and uses thereof |
| 07/22/2010 | WO2010083199A1 Benzthiazole inhibitors of poly(adp-ribose)polymerase |
| 07/22/2010 | WO2010083154A2 Heterofunctional segment-poly(ethylene glycol) polymers as delivery vehicles |
| 07/22/2010 | WO2010083107A1 Biocompatible microbubbles to deliver radioactive compounds to tumors, atherosclerotic plaques, joints and other targeted sites |
| 07/22/2010 | WO2010083104A2 Conjugates of noscapine and folic acid and their use in treating cancer |
| 07/22/2010 | WO2010082813A1 Method of treating cancer |
| 07/22/2010 | WO2010082789A2 Anticancer compositions comprising cedrol in nanoparticle form |
| 07/22/2010 | WO2010082612A1 Imidazothiazole derivative having proline ring structure |
| 07/22/2010 | WO2010082503A1 Gold complex and medicinal composition containing same |
| 07/22/2010 | WO2010082044A1 Unsaturated bicyclic heterocyclic derivatives as smo antagonists |
| 07/22/2010 | WO2010081890A1 Anti-kir3d antibodies |
| 07/22/2010 | WO2010081881A1 Aurora kinase inhibitors compounds. |
| 07/22/2010 | WO2010081877A1 Nitric oxide furoxan derivative compounds endowed with antitumoral activity |
| 07/22/2010 | WO2010081825A2 Pirenzepine as an agent in cancer treatment |
| 07/22/2010 | WO2010081817A1 Method for treating colorectal cancer |
| 07/22/2010 | WO2010081783A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 07/22/2010 | WO2010081778A1 Blockers of parp for the prevention and treatment of helicobacter pylori induced gastric cancer |
| 07/22/2010 | WO2010081488A1 Nitric oxide furoxan derivative compounds endowed with antitumoral activity |
| 07/22/2010 | WO2010081486A1 Compounds effective against cancer |
| 07/22/2010 | WO2010081266A1 A new use of tetrahydropalmatine |
| 07/22/2010 | WO2010081257A1 Composition comprising bacillus calmette guerin polysaccharides and bacillus calmette guerin nucleic acids and use of preparing medicament thereof |
| 07/22/2010 | WO2010062854A3 Methods and compositions for using bleomycin-derivatized microbubbles |
| 07/22/2010 | WO2010059004A9 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient |
| 07/22/2010 | WO2010057962A3 Crf conjugates with extended half-lives for use in inhibiting tumor progression |
| 07/22/2010 | WO2010055082A3 New crystal form of sunitinib malate |
| 07/22/2010 | WO2010051502A3 Light targeting molecules and uses thereof |
| 07/22/2010 | WO2010047611A9 Process for preparing chlorins and their pharmaceutical uses |
| 07/22/2010 | WO2010047607A3 Method of production of polyanionic drug-carrier conjugates |
| 07/22/2010 | WO2010045379A3 Pyridine non-classical cannabinoid compounds and related methods of use |
| 07/22/2010 | WO2010042600A3 Photo-activatable therapeutic agents and methods of using |
| 07/22/2010 | WO2010039518A3 Tricyclic carbamate jak inhibitors |
| 07/22/2010 | WO2010037095A3 Agents and methods for the treatment of cancer |
| 07/22/2010 | WO2010037059A3 Heteroaryl antagonists of prostaglandin d2 receptors |
| 07/22/2010 | WO2010036629A3 Fused multicyclic compounds as protein kinase inhibitors |
| 07/22/2010 | WO2010030666A3 Elimination of a contaminating non-human sialic acid by metabolic competition |
| 07/22/2010 | WO2010028259A3 9-aminonoscapine and its use in treating cancers, including drug- resistant cancers |
| 07/22/2010 | WO2010012745A3 Benzimidazoles |
| 07/22/2010 | WO2010012438A3 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 07/22/2010 | WO2009092278A8 Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses |
| 07/22/2010 | US20100186102 Methods and compositions for post-transcriptional gene silencing |
| 07/22/2010 | US20100184862 Prostacyclin derivatives |
| 07/22/2010 | US20100184854 Platinum (iv) complexes and methods of use thereof |
| 07/22/2010 | US20100184851 Inhibition of cell proliferation |
| 07/22/2010 | US20100184849 Urea oligomers, their preparation process and pharmaceutical compositions containing them |
| 07/22/2010 | US20100184843 Identification of a pin specific gene and protein (pin-1) useful as a diagnostic treatment for prostate cancer |
| 07/22/2010 | US20100184842 Ultraconserved Regions Encoding ncRNAs |
| 07/22/2010 | US20100184831 Materials and Complexes for the Delivery of Biologically-Active Materials to Cells |
| 07/22/2010 | US20100184830 Compositions and Methods for the Diagnosis and Therapy of BCL2-Associated Cancers |
| 07/22/2010 | US20100184828 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 07/22/2010 | US20100184826 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 07/22/2010 | US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 07/22/2010 | US20100184824 RNA Interference Mediated Inhibition of Interleukin and Interleukin Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 07/22/2010 | US20100184821 Compositions and Methods for Modulating Angiogenesis |
| 07/22/2010 | US20100184818 Photosensitizers for targeted photodynamic therapy |
| 07/22/2010 | US20100184812 Mutual prodrugs and methods to treat cancer |
| 07/22/2010 | US20100184809 Heterocyclic FXR Binding Compounds |
| 07/22/2010 | US20100184807 Methods to inhibit tumor cell growth by using proton pump inhibitors |
| 07/22/2010 | US20100184802 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 07/22/2010 | US20100184801 Fused amino pyridines for the treatment of brain tumors |
| 07/22/2010 | US20100184791 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/22/2010 | US20100184790 Pyrrolo[2,3-b]pyridine compounds, azaindole compounds used for synthesizing said pyrrolo[2,3-b]pyridine compounds, methods for the production thereof, and uses thereof |
| 07/22/2010 | US20100184787 Heataryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 07/22/2010 | US20100184782 Fused bicyclic pyrimidines |
| 07/22/2010 | US20100184779 Method for optimizing the treatment of chronic myeloid leukemia with abl tyrosine kinase inhibitors |
| 07/22/2010 | US20100184778 Novel heterocycle compounds and uses thereof |
| 07/22/2010 | US20100184774 Methods of treatment |
| 07/22/2010 | US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 07/22/2010 | US20100184766 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | US20100184765 Protein Kinase Inhibitors and Methods for Using Thereof |
| 07/22/2010 | US20100184763 Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 07/22/2010 | US20100184762 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 07/22/2010 | US20100184760 Benzoxazole kinase inhibitors and methods of use |
| 07/22/2010 | US20100184759 Pyrano-pyrazole-amines |
| 07/22/2010 | US20100184754 Quinolinone derivatives |
| 07/22/2010 | US20100184750 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | US20100184748 Compounds and compositions as itpkb inhibitors |
| 07/22/2010 | US20100184747 Indoline derivatives and their use in treating disease-states such as cancer |
| 07/22/2010 | US20100184745 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 07/22/2010 | US20100184741 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/22/2010 | US20100184739 Modulators of ATP-Binding Cassette Transporters |
| 07/22/2010 | US20100184718 Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells |
| 07/22/2010 | US20100184712 Hyperbranched polymers based on cyclodextrins and poly (amidoamines) for the controlled release of insoluble drugs |
| 07/22/2010 | US20100184711 Alpha-GLYCOSYL THIOLS AND alpha-S-LINKED GLYCOLIPIDS |
| 07/22/2010 | US20100184710 Therapeutic Bifunctional Compounds |
| 07/22/2010 | US20100184708 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/22/2010 | US20100184706 Fap-activated chemotherapeutic compounds, and methods of use thereof |
| 07/22/2010 | US20100184704 Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent |
| 07/22/2010 | US20100184702 Selective High-Affinity Polydentate Ligands and Methods of Making Such |
| 07/22/2010 | US20100184700 Preprocalcitonin antigen t epitopes |
| 07/22/2010 | US20100184699 Peptide Derived From Prostate-Related Protein As Cancer Vaccine Candidate For Prostate Cancer Patient Who Is Positive For Hla-A3 Super-Type Allele Molecule |
| 07/22/2010 | US20100184698 Use of a deslorelin and mastoparan as a therapeutic agent |
| 07/22/2010 | US20100184697 Peptide-based stat inhibitor |
| 07/22/2010 | US20100184695 Vascular endothelial cell-binding peptide |
| 07/22/2010 | US20100184694 T-140 peptide analogs having cxcr4 super-agonist activity for cancer therapy |
| 07/22/2010 | US20100184689 Pharmaceutical Composition Containing Botulinum Neurotoxin |
| 07/22/2010 | US20100184686 Use of inhibitors for the treatment of rtk-hyperfunction-induced disorders, particularly cancer |
| 07/22/2010 | US20100184680 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43 |
| 07/22/2010 | US20100184678 Use of a peptide as a therapeutic agent |